501332-69-0

Basic information

• Product Name: D-GlutaMic acid, N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxyMethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]aMino]benzoyl]-L-γ-glutaMyl-yl]aMino]benzoyl]-L-γ-glutaMyl-
• Synonyms: D-GlutaMic acid, N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxyMethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]aMino]benzoyl]-L-γ-glutaMyl-yl]aMino]benzoyl]-L-γ-glutaMyl-;BGC 945;NVHRBQOZEMFKLD-CUYJMHBOSA-N
• CAS NO: 501332-69-0
• Molecular Formula: C32H33N5O10
• Molecular Weight: 647.63192
• Mol File: 501332-69-0.mol
• Article Data: 0

Chemical Properties

• Melting Point: 174 °C(Solv: methanol (67-56-1); water (7732-18-5))
• Appearance: /
• Density: 1.49±0.1 g/cm3(Predicted)
• PKA: 3.39±0.10(Predicted)
• CAS DataBase Reference: D-GlutaMic acid, N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxyMethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]aMino]benzoyl]-L-γ-glutaMyl-yl]aMino]benzoyl]-L-γ-glutaMyl-(CAS DataBase Reference)
• NIST Chemistry Reference: D-GlutaMic acid, N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxyMethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]aMino]benzoyl]-L-γ-glutaMyl-yl]aMino]benzoyl]-L-γ-glutaMyl-(501332-69-0)
• EPA Substance Registry System: D-GlutaMic acid, N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxyMethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]aMino]benzoyl]-L-γ-glutaMyl-yl]aMino]benzoyl]-L-γ-glutaMyl-(501332-69-0)

Safety Data

• Hazardous Substances Data: 501332-69-0(Hazardous Substances Data)

Usage

General Description

D-Glutamic acid, N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-L-γ-glutamyl-yl]amino]benzoyl]-L-γ-glutamyl- is a complex chemical compound with a long name. It contains glutamic acid and a benzoyl group, as well as an amino acid chain. The compound also includes a cyclopentaquinazolinyl group and a propynyl group. It is a highly specialized and potentially significant molecule in the fields of chemistry and biochemistry, and it may have applications in pharmaceuticals or other areas of research.